Since it was approved by the FDa in 2006, the HPV vaccine has been primarily marketed to women. As Dr. Giuliano in the article explains, this is mainly because studies on the human papillomavirus focused on cervical cancer occurrence. Currently however, HPV has also been linked to genital warts (which is sexually transmitted) and cancer of the penis and anus. In fact, vaccination for HPV has been approved for men since 2009. This article and the topic it discusses definitely confront common stereotypes for both men and women. For one, HPV contraction is no longer a sole concern of women. As the research study by H. Lee Moffitt Cancer Center and Research Institute points out, there was a considerable decrease in genital warts development in sexually active men who were given the HPV shots. Thus, men can nowto take a more active role in the prevention of HPV transmission and even cervical cancer incidence. As Prof. Porche of LSU says, men are "vital component of the whole prevention cycle." It is thus admirable that the AAP has included the HPV vaccine in the list of recommended vaccinations for boys. And the bonus for parents is that the HPV vaccine is covered by most health insurance plans. If underinsured or uninsured, the article says that the government's program Vaccines for Children can help.